C. Cameron Yin

Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors

Jörge E. Cortes, Elias Jabbour, Hagop Kantarjian et al. · Blood · 2007 · 298 citations · Full text

Medicine, Hematology, Oncology +12

Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai–Dorfman disease

Sofía Garcés, L. Jeffrey Medeiros, Keyur P. Patel et al. · Modern Pathology · 2017 · 295 citations · Full text

Medicine, Genetics, Molecular Genetics +10

Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study

Elias Jabbour, Hagop M. Kantarjian, Farhad Ravandi et al. · The Lancet Oncology · 2015 · 280 citations

Medicine, Hematology, Oncology +13

B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome

Shaoying Li, Pei Lin, Luis Fayad et al. · Modern Pathology · 2011 · 248 citations · Full text

Medicine, Hematology, Oncology +15

Extranodal NK/T-cell Lymphoma, Nasal Type

Shaoying Li, Xiaoli Feng, Ting Li et al. · The American Journal of Surgical Pathology · 2012 · 199 citations

Medicine, Hematology, Oncology +11